The label for Novo Nordisk’s weight loss drug Ozempic now acknowledges some users’ reports of ileus, or intestinal blockage. In its update, however, the FDA said it’s difficult to confirm a causal ...

The label for the diabetes drug Ozempic — which has become popular for weight loss — now acknowledges reports of blocked intestines following use of the medication. The change comes after the Food and ...

Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers federal public health agencies. Ozempic now joins other products in this booming class of so-called GLP ...